Patents by Inventor Gary E. Archer

Gary E. Archer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay for anti-EGFRvIII antibodies
    Patent number: 8900816
    Abstract: Detection of human antibodies directed against the tumor-specific protein Epidermal Growth Factor Receptor variant Class III (EGFRvIII) provide information on tumor burden and vaccine response. The methods of the invention permit the specific identification of antibodies that are able to bind to EGFRvIII. The methods are useful in determining the presence of an EGFRvIII-expressing tumor and in detecting immune responses following immunization with EGFRvIII-derived peptide as part of a cancer immunotherapy regimen.
    Type: Grant
    Filed: July 21, 2008
    Date of Patent: December 2, 2014
    Assignee: Duke University
    Inventors: Robert J. Schmittling, Gary E. Archer, John H. Sampson, Darell D. Bigner
  • ASSAY FOR ANTI-EGFRvIII ANTIBODIES
    Publication number: 20120115739
    Abstract: Detection of human antibodies directed against the tumor-specific protein Epidermal Growth Factor Receptor variant Class III (EGFRvIII) provide information on tumor burden and vaccine response. The methods of the invention permit the specific identification of antibodies that are able to bind to EGFRvIII. The methods are useful in determining the presence of an EGFRvIII-expressing tumor and in detecting immune responses following immunization with EGFRvIII-derived peptide as part of a cancer immunotherapy regimen.
    Type: Application
    Filed: July 21, 2008
    Publication date: May 10, 2012
    Applicant: Duke University
    Inventors: Robert J. Schmittling, Gary E. Archer, John H. Sampson, Darell D. Bigner